Sonoma Pharmaceuticals, Inc.
SNOA
$5.09
$0.030.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.56M | -3.46M | -3.75M | -3.69M | -4.56M |
| Total Depreciation and Amortization | 135.00K | 138.00K | 148.00K | 160.00K | 170.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 173.00K | 755.00K | 332.00K | 426.00K | 506.00K |
| Change in Net Operating Assets | 2.06M | 2.48M | 3.43M | 1.59M | 789.00K |
| Cash from Operations | -1.19M | -88.00K | 159.00K | -1.51M | -3.10M |
| Capital Expenditure | -181.00K | -80.00K | -15.00K | -14.00K | 10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -181.00K | -80.00K | -15.00K | -14.00K | 10.00K |
| Total Debt Issued | 274.00K | 274.00K | 373.00K | 373.00K | 373.00K |
| Total Debt Repaid | -366.00K | -404.00K | -417.00K | -463.00K | -470.00K |
| Issuance of Common Stock | 2.43M | 3.16M | 3.46M | 4.11M | 2.54M |
| Repurchase of Common Stock | -1.00K | -1.00K | -1.00K | -1.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 5.00K | 5.00K |
| Cash from Financing | 2.34M | 3.03M | 3.41M | 4.02M | 2.45M |
| Foreign Exchange rate Adjustments | 52.00K | -616.00K | -724.00K | -555.00K | -317.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.02M | 2.25M | 2.83M | 1.94M | -955.00K |